Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Rectal Cancer”

1,795 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,795 results

Not applicableActive Not RecruitingNCT02874885
What this trial is testing

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectosigmoid Adenocarcinoma+10 more
M.D. Anderson Cancer Center 341
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056804
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Testing effectiveness (Phase 2)Study completedNCT00007943
What this trial is testing

Gemcitabine in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences 15
Early research (Phase 1)Study completedNCT05954871
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNon-Small Cell Lung Cancer
Genentech, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05969899
What this trial is testing

Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 50
Early research (Phase 1)Active Not RecruitingNCT06547385
What this trial is testing

Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ono Pharmaceutical Co. Ltd 40
Early research (Phase 1)UnknownNCT04843033
What this trial is testing

Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Nanjing Sanhome Pharmaceutical, Co., Ltd. 55
Testing effectiveness (Phase 2)Looking for participantsNCT05972655
What this trial is testing

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

Who this might be right for
Low Rectal Cancer
Sir Run Run Shaw Hospital 32
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Testing effectiveness (Phase 2)UnknownNCT05799820
What this trial is testing

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Who this might be right for
Colorectal Carcinoma
Qilu Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT04513223
What this trial is testing

SHR-A1811 in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Gastric CancerColorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 101
Large-scale testing (Phase 3)Study completedNCT00677443
What this trial is testing

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Samsung Medical Center 344
Testing effectiveness (Phase 2)UnknownNCT05480280
What this trial is testing

MFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Advanced/Metastatic Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 18
Testing effectiveness (Phase 2)Ended earlyNCT00209703
What this trial is testing

Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 30
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Load More Results